Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharma plans to enter into Japanese markets: Report

Date: 06-03-2014

Sun Pharmaceutical Industries is reportedly planning to enter into Japanese markets, an especially lucrative market for manufacturers of low-cost drugs, through partnerships or acquisitions. The company has expanded in the last few years, mainly through acquisitions, and it is looking out for more purchases.

Mumbai-based pharmaceutical company gets more than half its sales from the United States, the world’s biggest pharmaceuticals market.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.